Previous close | 4.8300 |
Open | 4.8700 |
Bid | 4.9700 x 3000 |
Ask | 4.9800 x 3100 |
Day's range | 4.7470 - 5.0100 |
52-week range | 4.4100 - 26.7500 |
Volume | |
Avg. volume | 4,700,380 |
Market cap | 2.047B |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
AUSTIN, Texas, May 07, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2024.
AUSTIN, Texas, May 07, 2024--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has formed long-term partnerships with five new physician practices across the U.S. to enable their transition to a full-risk, value-based care model. Recognized leaders in their respective communities, the new partners include Graves Gilbert Clinic in Kentucky, Mankato Clinic in Minnesota, Springfield Clinic in Illinois, and Twin
AUSTIN, Texas, April 16, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.